| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
A Stock Overview
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Agilent Technologies Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$133.61 |
| 52 Week High | US$179.57 |
| 52 Week Low | US$112.52 |
| Beta | 1.06 |
| 1 Month Change | 9.06% |
| 3 Month Change | 18.12% |
| 1 Year Change | -14.19% |
| 3 Year Change | 94.65% |
| 5 Year Change | 125.20% |
| Change since IPO | 212.54% |
Recent News & Updates
Agilent Technologies acquires Polymer Standards Service; terms undisclosed
Agilent Technologies (NYSE:A) said Tuesday it acquired Polymer Standards Service (PSS); financial terms were not disclosed. PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures. The acquisition expands A's product portfolio and customer offerings, particularly in chemical and biopharmaceutical industries for analysis of natural and synthetic polymers. A will also add a key software component to complement its gel permeation chromatography/size exclusion chromatography product portfolio. A's global presence will help to expand the use of PSS products and expertise more widely.
Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
How far off is Agilent Technologies, Inc. ( NYSE:A ) from its intrinsic value? Using the most recent financial data...
Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?
Let's talk about the popular Agilent Technologies, Inc. ( NYSE:A ). The company's shares received a lot of attention...
Shareholder Returns
| A | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -0.4% | -0.7% | 1.0% |
| 1Y | -14.2% | -20.5% | -12.9% |
Return vs Industry: A exceeded the US Life Sciences industry which returned -20.5% over the past year.
Return vs Market: A underperformed the US Market which returned -12.9% over the past year.
Price Volatility
| A volatility | |
|---|---|
| A Average Weekly Movement | 5.1% |
| Life Sciences Industry Average Movement | 11.1% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: A is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: A's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 17,400 | Mike McMullen | https://www.agilent.com |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide.
Agilent Technologies Fundamentals Summary
| A fundamental statistics | |
|---|---|
| Market Cap | US$39.91b |
| Earnings (TTM) | US$1.26b |
| Revenue (TTM) | US$6.53b |
31.6x
P/E Ratio6.1x
P/S RatioIs A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A income statement (TTM) | |
|---|---|
| Revenue | US$6.53b |
| Cost of Revenue | US$3.00b |
| Gross Profit | US$3.52b |
| Other Expenses | US$2.26b |
| Earnings | US$1.26b |
Last Reported Earnings
Apr 30, 2022
Next Earnings Date
Aug 16, 2022
| Earnings per share (EPS) | 4.23 |
| Gross Margin | 53.97% |
| Net Profit Margin | 19.35% |
| Debt/Equity Ratio | 56.7% |
How did A perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield19%
Payout RatioValuation
Is A undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for A?
Other financial metrics that can be useful for relative valuation.
| What is A's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | US$39.91b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 6.4x |
| Enterprise Value/EBITDA | 22.6x |
| PEG Ratio | 3.3x |
Price to Earnings Ratio vs Peers
How does A's PE Ratio compare to its peers?
| A PE Ratio vs Peers |
|---|
| Company | PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 40.4x | ||
IQV IQVIA Holdings | 37.7x | 17.9% | US$43.8b |
ILMN Illumina | 50.1x | 27.4% | US$35.2b |
MTD Mettler-Toledo International | 37x | 9.0% | US$30.3b |
WST West Pharmaceutical Services | 36.9x | 9.0% | US$25.3b |
A Agilent Technologies | 31.6x | 9.7% | US$39.9b |
Price-To-Earnings vs Peers: A is good value based on its Price-To-Earnings Ratio (31.6x) compared to the peer average (40.4x).
Price to Earnings Ratio vs Industry
How does A's PE Ratio compare vs other companies in the US Life Sciences Industry?
Price-To-Earnings vs Industry: A is good value based on its Price-To-Earnings Ratio (31.6x) compared to the US Life Sciences industry average (33.6x)
Price to Earnings Ratio vs Fair Ratio
What is A's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 31.6x |
| Fair PE Ratio | 25.8x |
Price-To-Earnings vs Fair Ratio: A is expensive based on its Price-To-Earnings Ratio (31.6x) compared to the estimated Fair Price-To-Earnings Ratio (25.8x).
Share Price vs Fair Value
What is the Fair Price of A when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: A ($133.61) is trading below our estimate of fair value ($145.53)
Significantly Below Fair Value: A is trading below fair value, but not by a significant amount.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Future Growth
How is Agilent Technologies forecast to perform in the next 1 to 3 years based on estimates from 15 analysts?
Future Growth Score
2/6Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
9.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A's forecast earnings growth (9.7% per year) is above the savings rate (1.9%).
Earnings vs Market: A's earnings (9.7% per year) are forecast to grow slower than the US market (12.9% per year).
High Growth Earnings: A's earnings are forecast to grow, but not significantly.
Revenue vs Market: A's revenue (6.4% per year) is forecast to grow slower than the US market (7.9% per year).
High Growth Revenue: A's revenue (6.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A's Return on Equity is forecast to be high in 3 years time (27.9%)
Discover growth companies
Past Performance
How has Agilent Technologies performed over the past 5 years?
Past Performance Score
6/6Past Performance Score 6/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
18.1%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A has high quality earnings.
Growing Profit Margin: A's current net profit margins (19.4%) are higher than last year (15.9%).
Past Earnings Growth Analysis
Earnings Trend: A's earnings have grown by 18.1% per year over the past 5 years.
Accelerating Growth: A's earnings growth over the past year (36.5%) exceeds its 5-year average (18.1% per year).
Earnings vs Industry: A earnings growth over the past year (36.5%) exceeded the Life Sciences industry 15.9%.
Return on Equity
High ROE: A's Return on Equity (24.7%) is considered high.
Discover strong past performing companies
Financial Health
How is Agilent Technologies's financial position?
Financial Health Score
5/6Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: A's short term assets ($3.6B) exceed its short term liabilities ($1.8B).
Long Term Liabilities: A's short term assets ($3.6B) exceed its long term liabilities ($3.5B).
Debt to Equity History and Analysis
Debt Level: A's net debt to equity ratio (33.2%) is considered satisfactory.
Reducing Debt: A's debt to equity ratio has increased from 46.7% to 56.7% over the past 5 years.
Debt Coverage: A's debt is well covered by operating cash flow (45.2%).
Interest Coverage: A's interest payments on its debt are well covered by EBIT (18.7x coverage).
Balance Sheet
Discover healthy companies
Dividend
What is Agilent Technologies's current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Cash Flow Coverage
0.63%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: A's dividend (0.63%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.52%).
High Dividend: A's dividend (0.63%) is low compared to the top 25% of dividend payers in the US market (4.09%).
Stability and Growth of Payments
Stable Dividend: A is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: A is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Earnings Payout to Shareholders
Earnings Coverage: A is not paying a notable dividend for the US market.
Cash Payout to Shareholders
Cash Flow Coverage: A is not paying a notable dividend for the US market.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
7.3yrs
Average management tenure
CEO
Mike McMullen (61 yo)
7.92yrs
Tenure
US$15,967,631
Compensation
Mr. Michael R. McMullen, also known as Mike, has been the President of Agilent Technologies, Inc., since September 17, 2014 and Chief Executive Officer since March 18, 2015. Mr. McMullen has been a Directo...
CEO Compensation Analysis
Compensation vs Market: Mike's total compensation ($USD15.97M) is about average for companies of similar size in the US market ($USD12.96M).
Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: A's management team is seasoned and experienced (7.3 years average tenure).
Board Members
Experienced Board: A's board of directors are considered experienced (6.9 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: A insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Agilent Technologies, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Agilent Technologies, Inc.
- Ticker: A
- Exchange: NYSE
- Founded: 1999
- Industry: Life Sciences Tools and Services
- Sector: Pharmaceuticals & Biotech
- Implied Market Cap: US$39.910b
- Shares outstanding: 298.71m
- Website: https://www.agilent.com
Number of Employees
Location
- Agilent Technologies, Inc.
- 5301 Stevens Creek Boulevard
- Santa Clara
- California
- 95051
- United States
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/08/07 00:00 |
| End of Day Share Price | 2022/08/05 00:00 |
| Earnings | 2022/04/30 |
| Annual Earnings | 2021/10/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.